These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1426672)
1. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays. Bessler WG Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672 [TBL] [Abstract][Full Text] [Related]
2. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908 [TBL] [Abstract][Full Text] [Related]
4. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes. Roth A; Espuelas S; Thumann C; Frisch B; Schuber F Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182 [TBL] [Abstract][Full Text] [Related]
6. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein. Bessler WG; Johnson RB; Wiesmüller K; Jung G Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983 [TBL] [Abstract][Full Text] [Related]
7. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. Radolf JD; Arndt LL; Akins DR; Curetty LL; Levi ME; Shen Y; Davis LS; Norgard MV J Immunol; 1995 Mar; 154(6):2866-77. PubMed ID: 7876555 [TBL] [Abstract][Full Text] [Related]
8. [Lipopeptides as natural adjuvants for vaccines from Gram-negative bacteria]. Schlecht S; Wiesmüller KH; Jung G; Bessler WG Naturwissenschaften; 1993 Jan; 80(1):9-17. PubMed ID: 8446175 [TBL] [Abstract][Full Text] [Related]
9. Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. Metzger JW; Beck-Sickinger AG; Loleit M; Eckert M; Bessler WG; Jung G J Pept Sci; 1995; 1(3):184-90. PubMed ID: 9222995 [TBL] [Abstract][Full Text] [Related]
10. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Wiesmüller KH; Jung G; Gillessen D; Loffl C; Bessler WG; Böltz T Immunology; 1991 Jan; 72(1):109-13. PubMed ID: 1705236 [TBL] [Abstract][Full Text] [Related]
12. Rapid alterations in the plasma membrane structure of macrophages stimulated with bacterial lipopeptides. Uhl B; Speth V; Wolf B; Jung G; Bessler WG; Hauschildt S Eur J Cell Biol; 1992 Jun; 58(1):90-8. PubMed ID: 1644066 [TBL] [Abstract][Full Text] [Related]
13. Preparation of human and murine monoclonal antibodies: antigens combined with or conjugated to lipopeptides constitute potent immunogens for in vitro and in vivo immunizations. Hoffmann P; Jimenez-Diaz M; Loleit M; Tröger W; Wiesmüller KH; Metzger J; Jung G; Kaiser I; Stöcklin S; Lenzner S Hum Antibodies Hybridomas; 1990; 1(3):137-44. PubMed ID: 2103357 [TBL] [Abstract][Full Text] [Related]
14. Comparison of biologic activities of synthetic lipopentapeptide analogs of bacterial lipoprotein in mice. Shimizu T; Ohtsuka Y; Yanagihara Y; Kurimura M; Takemoto M; Achiwa K Mol Biother; 1991 Mar; 3(1):46-50. PubMed ID: 2069759 [TBL] [Abstract][Full Text] [Related]
15. Polyclonal B-cell activation by a synthetic analogue of bacterial lipoprotein is functionally different from activation by bacterial lipopolysaccharide. Kleine B; Sprenger R; Martinez-Alonso C; Bessler WG Immunology; 1987 May; 61(1):29-34. PubMed ID: 3495485 [TBL] [Abstract][Full Text] [Related]
16. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo. Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288 [TBL] [Abstract][Full Text] [Related]
18. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines. Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175 [TBL] [Abstract][Full Text] [Related]
19. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. Lex A; Wiesmüller KH; Jung G; Bessler WG J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339 [TBL] [Abstract][Full Text] [Related]
20. Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants. Kleine B; Rapp W; Wiesmüller KH; Edinger M; Beck W; Metzger J; Ataulakhanov R; Jung G; Bessler WG Immunobiology; 1994 Feb; 190(1-2):53-66. PubMed ID: 8082887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]